Jimstan N. Periselneris

Denmark Hill
London, ENG SE59RS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA).

Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA).

Journal: Systematic reviews

Published: April 28, 2025

The Effects of COVID-19 on Antifungal Prescribing in the UK-Lessons to Learn.

The Effects of COVID-19 on Antifungal Prescribing in the UK-Lessons to Learn.

Journal: Journal of fungi (Basel, Switzerland)

Published: October 01, 2024

Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England.

Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England.

Journal: The Journal of infection

Published: December 12, 2022

Breaking the mould, a first parse at natural language processing in aspergillosis diagnosis.

Breaking the mould, a first parse at natural language processing in aspergillosis diagnosis.

Journal: Journal of thoracic disease

Published: October 07, 2022

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.

Journal: Nature communications

Published: September 26, 2022

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: July 14, 2022

Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae.

Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae.

Journal: Immunology

Published: January 10, 2022

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.

Journal: PloS one

Published: July 19, 2021

The perils of a persistent cough.

The perils of a persistent cough.

Journal: Breathe (Sheffield, England)

Published: December 11, 2020

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.

Journal: ERJ open research

Published: September 09, 2020

Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.

Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.

Journal: Nature communications

Published: August 27, 2020

Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study.

Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study.

Journal: Critical care research and practice

Published: August 13, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026